Phase II study of docetaxel and capecitabine as 1st line therapy for patients with locally advanced or metastatic gastric cancer

Trial Profile

Phase II study of docetaxel and capecitabine as 1st line therapy for patients with locally advanced or metastatic gastric cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2007

At a glance

  • Drugs Capecitabine; Docetaxel
  • Indications Gastric cancer; Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top